President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in ...
Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market - Targeting Q1 2026 for expected clearance of the MODD1 in ...
Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, ...
Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...
Ever-Growing USA on MSN2d
Insulin Outlet Joins the Fight for Affordable Healthcare for AllAs the rising cost of insulin continues to make it difficult for so many diabetic patients to receive life-saving care, ...
A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...
Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback